Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca

Author： Janero David R  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.6, 2012-06, pp. : 449-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Considerations on English as a Global Lingua Franca

By  

POLITICAL STUDIES REVIEW, Vol. 13, Iss. 3, 2015-08 ,pp. : 363-372

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabonomics in preclinical drug development

By Robertson Donald G   Reily Michael D   Baker J David  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

A Review of: "Preclinical Drug Development"

By Keep Marcus F.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 4, 2007-04 ,pp. : 493-493

Informa Healthcare

Access to resources Recommend Favorite

Application of Pharmacogenomics in Drug Discovery and Development:Correlations Between Transcriptional Modulation and Preclinical Safety Observations

By  

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 41-48

Bentham Science Publishers

Access to resources Recommend Favorite

Using Drosophila models of neurodegenerative diseases for drug discovery

By Newman Tracey   Sinadinos Christopher   Johnston Alex   Sealey Megan   Mudher Amrit  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 129-140

Informa Healthcare

Access to resources Recommend Favorite